2-[4-(2H-1,3-benzodioxol-5-yl)-1-(4-methoxyphenyl)-7-oxo-3-phenyl-1,4,6,7-tetrahydro-8H-pyrazolo[3,4-e][1,4]thiazepin-8-yl]-N-(propan-2-yl)acetamide
Chemical Structure Depiction of
2-[4-(2H-1,3-benzodioxol-5-yl)-1-(4-methoxyphenyl)-7-oxo-3-phenyl-1,4,6,7-tetrahydro-8H-pyrazolo[3,4-e][1,4]thiazepin-8-yl]-N-(propan-2-yl)acetamide
2-[4-(2H-1,3-benzodioxol-5-yl)-1-(4-methoxyphenyl)-7-oxo-3-phenyl-1,4,6,7-tetrahydro-8H-pyrazolo[3,4-e][1,4]thiazepin-8-yl]-N-(propan-2-yl)acetamide
Compound characteristics
Compound ID: | V010-4651 |
Compound Name: | 2-[4-(2H-1,3-benzodioxol-5-yl)-1-(4-methoxyphenyl)-7-oxo-3-phenyl-1,4,6,7-tetrahydro-8H-pyrazolo[3,4-e][1,4]thiazepin-8-yl]-N-(propan-2-yl)acetamide |
Molecular Weight: | 570.67 |
Molecular Formula: | C31 H30 N4 O5 S |
Smiles: | CC(C)NC(CN1C(CSC(c2ccc3c(c2)OCO3)c2c(c3ccccc3)nn(c3ccc(cc3)OC)c12)=O)=O |
Stereo: | RACEMIC MIXTURE |
logP: | 5.167 |
logD: | 5.167 |
logSw: | -5.0446 |
Hydrogen bond acceptors count: | 9 |
Hydrogen bond donors count: | 1 |
Polar surface area: | 78.401 |
InChI Key: | XBBDONVIVVNEFB-SSEXGKCCSA-N |